RxSight Inc. (RXST)
RXST trades on Nasdaq in Health Care, Ophthalmic Goods. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$4.53
-2.79% on the day
Market cap
$188.4M
Micro cap
Revenue · 2025
$134.5M
-3.9% on 2024
Net income · 2025
-$39
-0.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | RXST on Nasdaq |
| Sector | Health Care |
| Industry | Ophthalmic Goods |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001111485 |
| SEC industry code | Ophthalmic Goods |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $134.5M |
| Net income | -$39 |
| Operating income | -$48.2M |
| Net margin | -0.0% |
| Operating margin | -35.8% |
| Revenue growth | -3.9% |
| Cash | $19.9M |
| Total assets | $311.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.4× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | POS AM | 2026-02-25 |
| Latest annual report | 10-K | 2026-02-25 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-08-05 |
| Latest proxy | DEFA14A | 2026-04-28 |
Source: SEC EDGAR submissions feed, 468 recent filings. All filings on EDGAR.
Peers in Ophthalmic Goods
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| STAA | STAAR Surgical Company | $21.50 | -2.32% | $1.1B |
| EYE | National Vision Holdings Inc. | $17.04 | -0.18% | $1.3B |
| WRBY | Warby Parker Inc. | $26.52 | +2.04% | $3.3B |
| LUCY | Innovative Eyewear Inc. | $0.8524 | -3.43% | $7.4M |
| BLCO | Bausch + Lomb Corporation Common Shares | $15.81 | -1.62% | $5.6B |
| COO | The Cooper Companies Inc. | $54.59 | -1.72% | $10.4B |
| ALC | Alcon Inc. | $63.00 | -2.10% | $31.5B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier